Ticker	Volume	Price	Price Delta
DJIA	12,454.80	-74.92	-0.60%
S&P 500	1,317.82	-2.86	-0.22%
Nasdaq	2,837.53	-1.85	-0.07%

Ticker

Volume

Price

Price Delta

DJIA

12,454.80

-74.92

-0.60%

S&P 500

1,317.82

-2.86

-0.22%

Nasdaq

2,837.53

-1.85

-0.07%

Ticker	Volume	Price	Price Delta
STOXX 50	2,161.87	+5.35	0.25%
FTSE 100	5,351.53	+1.48	0.03%
DAX	6,339.94	+24.05	0.38%

Ticker

Volume

Price

Price Delta

STOXX 50

2,161.87

+5.35

0.25%

FTSE 100

5,351.53

+1.48

0.03%

DAX

6,339.94

+24.05

0.38%

Ticker	Volume	Price	Price Delta
Nikkei	8,580.39	+17.01	0.20%
TOPIX	722.11	-0.14	-0.02%
Hang Seng	18,713.40	+47.01	0.25%

Ticker

Volume

Price

Price Delta

Nikkei

8,580.39

+17.01

0.20%

TOPIX

722.11

-0.14

-0.02%

Hang Seng

18,713.40

+47.01

0.25%

Nutrition 21 Supplement Maker Files Bankruptcy with $122.8 Million in Debt

By Tiffany Kary - 2011-08-26T20:00:28Z

Nutrition 21 Inc. (NXXI), a developer of pharmaceutical type supplements, filed for bankruptcy in White Plains, New York.

The Chapter 11 petition today listed $122.8 million in liabilities and less than $7.2 million in assets. Subsidiaries Heart’s Content Inc., Iceland Health LLC and Nutrition 21 LLC also filed. The Purchase, New York-based company’s products include Chromax chromium picolinate and Zinmax zinc picolinate, according to its website.

Revenue comes from sale of patented ingredients to vitamin and supplement makers, for human and animal nutrition, according to the company’s website.

The case is In re Nutrition 21 LLC, 11-23712, Southern District of New York (Manhattan).

To contact the reporter on this story: Tiffany Kary in New York at tkary@bloomberg.net.

To contact the editor responsible for this story: Michael Hytha at mhytha@bloomberg.net.